Combination of IgG N-glycomics and corresponding transcriptomics data to identify anti-TNF-α treatment responders in inflammatory diseases

Csaba Váradi, Zsolt Holló, Szilárd Póliska, Laszlo Nagy, Zoltán Szekanecz, Andrea Váncsa, Károly Palatka, András Guttman

Research output: Contribution to journalArticle

Abstract

Prediction of responsiveness in biological therapies is an important and challenging issue in different diseases. Analyzing glycosylation pattern changes of key serum glycoproteins is one of the possible avenues to follow disease remission. The aim of this study was to investigate the changes of serum IgG glycoforms in Crohn's disease (CD) and rheumatoid arthritis patients in response to antitumor necrosis factor alpha (anti-TNF-α) treatment. IgG was isolated from patient serum samples using Protein A affinity pull-down, followed by the release of N-glycans with peptide-N-glycosidase F. The released glycans were fluorescently tagged with 8-aminopyrene-1,3,6-trisulfonate and analyzed by CGE with laser-induced fluorescent detection. Significant alterations were detected between responders and nonresponders in both disease groups. In CD patients, disease-specific alteration was found in response to anti-TNF-α therapy, which was also confirmed by transcriptomics data analysis of the corresponding glycosyltransferases and glycosidases.

Original languageEnglish (US)
Pages (from-to)1330-1335
Number of pages6
JournalElectrophoresis
Volume36
Issue number11-12
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Glycomics
Necrosis
Immunoglobulin G
Crohn Disease
Polysaccharides
Serum
Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase
Glycosyltransferases
Biological Therapy
Glycoside Hydrolases
Staphylococcal Protein A
Therapeutics
Glycosylation
Rheumatoid Arthritis
Glycoproteins
Lasers

Keywords

  • Capillary electrophoresis
  • Glycosylation
  • IgG

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Combination of IgG N-glycomics and corresponding transcriptomics data to identify anti-TNF-α treatment responders in inflammatory diseases. / Váradi, Csaba; Holló, Zsolt; Póliska, Szilárd; Nagy, Laszlo; Szekanecz, Zoltán; Váncsa, Andrea; Palatka, Károly; Guttman, András.

In: Electrophoresis, Vol. 36, No. 11-12, 01.01.2015, p. 1330-1335.

Research output: Contribution to journalArticle

Váradi, Csaba ; Holló, Zsolt ; Póliska, Szilárd ; Nagy, Laszlo ; Szekanecz, Zoltán ; Váncsa, Andrea ; Palatka, Károly ; Guttman, András. / Combination of IgG N-glycomics and corresponding transcriptomics data to identify anti-TNF-α treatment responders in inflammatory diseases. In: Electrophoresis. 2015 ; Vol. 36, No. 11-12. pp. 1330-1335.
@article{466868e38a7a458e807c879830ac3fbb,
title = "Combination of IgG N-glycomics and corresponding transcriptomics data to identify anti-TNF-α treatment responders in inflammatory diseases",
abstract = "Prediction of responsiveness in biological therapies is an important and challenging issue in different diseases. Analyzing glycosylation pattern changes of key serum glycoproteins is one of the possible avenues to follow disease remission. The aim of this study was to investigate the changes of serum IgG glycoforms in Crohn's disease (CD) and rheumatoid arthritis patients in response to antitumor necrosis factor alpha (anti-TNF-α) treatment. IgG was isolated from patient serum samples using Protein A affinity pull-down, followed by the release of N-glycans with peptide-N-glycosidase F. The released glycans were fluorescently tagged with 8-aminopyrene-1,3,6-trisulfonate and analyzed by CGE with laser-induced fluorescent detection. Significant alterations were detected between responders and nonresponders in both disease groups. In CD patients, disease-specific alteration was found in response to anti-TNF-α therapy, which was also confirmed by transcriptomics data analysis of the corresponding glycosyltransferases and glycosidases.",
keywords = "Capillary electrophoresis, Glycosylation, IgG",
author = "Csaba V{\'a}radi and Zsolt Holl{\'o} and Szil{\'a}rd P{\'o}liska and Laszlo Nagy and Zolt{\'a}n Szekanecz and Andrea V{\'a}ncsa and K{\'a}roly Palatka and Andr{\'a}s Guttman",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/elps.201400575",
language = "English (US)",
volume = "36",
pages = "1330--1335",
journal = "Electrophoresis",
issn = "0173-0835",
publisher = "Wiley-VCH Verlag",
number = "11-12",

}

TY - JOUR

T1 - Combination of IgG N-glycomics and corresponding transcriptomics data to identify anti-TNF-α treatment responders in inflammatory diseases

AU - Váradi, Csaba

AU - Holló, Zsolt

AU - Póliska, Szilárd

AU - Nagy, Laszlo

AU - Szekanecz, Zoltán

AU - Váncsa, Andrea

AU - Palatka, Károly

AU - Guttman, András

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Prediction of responsiveness in biological therapies is an important and challenging issue in different diseases. Analyzing glycosylation pattern changes of key serum glycoproteins is one of the possible avenues to follow disease remission. The aim of this study was to investigate the changes of serum IgG glycoforms in Crohn's disease (CD) and rheumatoid arthritis patients in response to antitumor necrosis factor alpha (anti-TNF-α) treatment. IgG was isolated from patient serum samples using Protein A affinity pull-down, followed by the release of N-glycans with peptide-N-glycosidase F. The released glycans were fluorescently tagged with 8-aminopyrene-1,3,6-trisulfonate and analyzed by CGE with laser-induced fluorescent detection. Significant alterations were detected between responders and nonresponders in both disease groups. In CD patients, disease-specific alteration was found in response to anti-TNF-α therapy, which was also confirmed by transcriptomics data analysis of the corresponding glycosyltransferases and glycosidases.

AB - Prediction of responsiveness in biological therapies is an important and challenging issue in different diseases. Analyzing glycosylation pattern changes of key serum glycoproteins is one of the possible avenues to follow disease remission. The aim of this study was to investigate the changes of serum IgG glycoforms in Crohn's disease (CD) and rheumatoid arthritis patients in response to antitumor necrosis factor alpha (anti-TNF-α) treatment. IgG was isolated from patient serum samples using Protein A affinity pull-down, followed by the release of N-glycans with peptide-N-glycosidase F. The released glycans were fluorescently tagged with 8-aminopyrene-1,3,6-trisulfonate and analyzed by CGE with laser-induced fluorescent detection. Significant alterations were detected between responders and nonresponders in both disease groups. In CD patients, disease-specific alteration was found in response to anti-TNF-α therapy, which was also confirmed by transcriptomics data analysis of the corresponding glycosyltransferases and glycosidases.

KW - Capillary electrophoresis

KW - Glycosylation

KW - IgG

UR - http://www.scopus.com/inward/record.url?scp=84930571978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930571978&partnerID=8YFLogxK

U2 - 10.1002/elps.201400575

DO - 10.1002/elps.201400575

M3 - Article

C2 - 25639738

AN - SCOPUS:84930571978

VL - 36

SP - 1330

EP - 1335

JO - Electrophoresis

JF - Electrophoresis

SN - 0173-0835

IS - 11-12

ER -